MedTrace Logo

Lithotripsy for the Treatment of Gallstones

NCT00042549 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2005-06-24

No results posted yet for this study

Summary

The purpose of this study is to determine the effectiveness and safety of using the Medstone lithotripter to treat single non-calcified gallstones from 4 to 20 mm in diameter.

Conditions

Interventions

DEVICE

Extracorporeal Shock Wave Lithotripsy

DRUG

ursodiol

Sponsors & Collaborators

  • Medstone International

    lead INDUSTRY

Principal Investigators

  • Atilla Ertan, M.D. · The Methodist Hospital Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00042549 on ClinicalTrials.gov